What is the Antibody Registry
The Antibody Registry exists to give researchers a way to universally identify antibodies used in publications. The registry lists many commercial antibodies from about 200 vendors, which have been assigned a unique identifier. If the antibody that you are using does not appear in the list, an entry can be made by filling in as little as 2 pieces of information: the catalog number and the url of the vendor where our curators can find information and material data sheets. Many optional fields can also be filled in that will help curators identify the reagent. After submitting an antibody, you are given a permanent identifier that can be used in publications. This identifier even if it is later found to be a duplicate, can be quickly traced back in the antibody registry. We never delete records, but we collapse duplicate entries on a regular basis (the old identifiers are kept to help with search).
Type in your search terms in the box above and antibodies that most closely match what you searched will be returned to you.
Features of the Antibody Registry
With the most recent update, the Antibody Registry has become even easier to use. The same search functionality is included, just presented in a nicer way. Adding an antibody has been improved to let you know what is really important to identifying your antibody.
The newest and most powerful addition is the integration with the NIF (Neuroscience Information Framework) user system. If you have a NIF account you can log in above and all of your information from NIF carries over. You can now save your antibody search. You also must be logged in to add an antibody and the added antibody will be linked to your account so you can keep track of it.
Integration with The Journal of Comparative Neurology
The AntibodyRegistry is proud to announce that as of May 2011 we are working with the antibody database provided by the Journal of Comparative Neurology. This database has been created by the careful work of Dr. Clifford Saper, who had implemented a visionary policy that requires a rigorous categorization of all antibodies used in all manuscripts submitted to the journal. This collaboration allows the antibody registry to add important links between the antibodies in heavy use and all antibodies available for a particular antigen, especially those useful for neuroscience. The simple search of the registry has also been updated to reflect the relative importance of the antibodies used in the Journal of Comparative Neurology papers.